BioSpace News Archive

Biotech Beach

Halozyme Announces Approval Of Subcutaneous Formulation Of Trastuzumab (Herceptin®) In Canada

This is a co-formulation with Halozyme’s proprietary recombinant human hyaluronidase enzyme.

September 17, 2018
·
3 min read
Drug Development

CartiHeal Performs First Hungarian Case in the Agili-C™ Implant IDE Multinational Pivotal Study

Successful enrollment of the first Hungarian patient in the Agili-C IDE pivotal study.

September 17, 2018
·
2 min read
Pharm Country

Data Cubed Takes Second-Place in Robert Wood Johnson Foundation Opioid Challenge For Video Game App that Fights Addiction

Data Cubed, a life-sciences technology company, won second place in the Robert Wood Johnson Foundation Opioid Challenge for its Resilience IQ (ResQ) platform, the company announced today at the 12th Annual Health 2.0 Conference in Santa Clara, California.

September 17, 2018
·
3 min read
Business

QIAGEN and NeuMoDx Announce Strategic Partnership to Offer Next-Generation Systems for Fully Integrated Molecular Diagnostic Testing

QIAGEN to launch two Sample to Insight systems in Europe and other markets, NeuMoDx to commercialize in the U.S. / Initial assay menu for infectious diseases and LDTs

September 17, 2018
·
2 min read
Business

Virion Appoints Vanessa King as President & CEO and Isabel Najera as CSO

Building Team to Transform Respiratory Virus Infection Management using Therapeutic Interfering Particles

September 17, 2018
·
4 min read
Lone Star Bio

Low T Center Expands Services to Help Men with their Overall Health & Wellness

Low T Center is excited to announce its evolution as a men’s health provider with the expansion of treatment services.

September 17, 2018
·
2 min read
Lone Star Bio

BroadJump Introduces Dynamic Spend Intelligence at IDN Fall Summit 2018

New platform unites healthcare expense data in a single dashboard

September 17, 2018
·
2 min read
Business

Samumed And United Therapeutics Announce North American License Agreement For Samumed’s IPF Drug Candidate

Samumed LLC has entered an exclusive license agreement with United Therapeutics Corporation (Nasdaq: UTHR) for North American rights to Samumed’s SM04646, being developed for the treatment of idiopathic pulmonary fibrosis (IPF).

September 17, 2018
·
4 min read
Deals

FIRMENICH TO ACQUIRE SENOMYX, PIONEER IN TASTE INNOVATION

Firmenich and Senomyx, Inc. today announced that they have entered into a definitive merger agreement under which Firmenich will acquire all of the outstanding common stock of Senomyx for $1.50 per share in cash.

September 17, 2018
·
8 min read
Business

Eternity Healthcare Inc. Expects to Complete Stem Cell Facility and Commence Operations by the End of Year and Declare a 2.5 for 1 Stock Dividend

Eternity Healthcare Inc. today announced that it expects to complete the construction and outfitting of its stem cell facility in Guizhou, Tongren, China, by the end of calendar year 2018.

September 17, 2018
·
2 min read